Sexually Transmitted Disease Surveillance 1996
Division of STD Prevention September 1997 U.S. Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention National Center for HIV, STD, and TB Prevention Division of STD Prevention Atlanta, Georgia 30333 Copyright Information All material contained in this report is in the public domain and may be used and reprinted without special permission; citation to source, however, is appreciated. Suggested Citation Division of STD Prevention. Sexually Transmitted Disease Surveillance, 1996. U.S. Department of Health and Human Services, Public Health Service. Atlanta: Centers for Disease Control and Prevention, September 1997. Copies can be obtained from the Office of Communications, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E-06, Atlanta, Georgia 30333. The reports for 1993 through 1996 are available electronically on CDC WONDER. For information about registering for CDC WONDER, please contact CDC's Epidemiology Program Office at (888) 496-8347. These reports are also available from the Internet via the CDC home page address http://wonder.cdc.gov/wonder/data/Reports.html. STDs in the South Public Health Impact The southern region (Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia) has had higher rates of primary and secondary (P&S) syphilis and gonorrhea than other regions of the country. The reasons for regional differences in rates are not well understood, but may include differences in racial and ethnic distribution of the population, poverty, and availability and quality of health care services. These racial and ethnic differentials in STD rates are particularly disturbing in light of the fact that STDs facilitate HIV transmission at least two to five fold. High HIV prevalence among childbearing women living in the South may be due, in part, to the high rates of these other STDs. Data from a randomized controlled trial of STD treatment to prevent HIV infection suggest that as much as a 40% reduction in HIV incidence might be achieved in areas with high STD rates (1). Observations -- The South has consistently had higher rates of both gonorrhea and P&S syphilis compared with other regions throughout the 1980's and 1990's (Figure_12, Figure_13, Figure_25, Figure_27, Table_14 and Table_26). In 1996, the South also had the highest rate of Chlamydia (Figure_3, Table_5) compared to the other regions. -- In 1996, 6 of the 10 states with the highest chlamydia rates were in the South (Table_4). Similarly, the 10 states with the highest rates of gonorrhea were all located in the South (Figure_12, Table_13). Twelve of 16 states with rates of P&S syphilis above the HP2000 objective of 4 per 100,000 persons were located in the South (Figure_25 and Figure_26, Table_25). All 8 states with rates of P&S syphilis that exceeded 10 cases per 100,000 population (or 2.5 times the HP2000 national objective) were located in the South (Figure_25, Table_25). -- In 1996, 429 (89%) of 482 counties with P&S syphilis rates above the HP2000 objective were located in the South (Figure_26 and Figure_T). -- Of the 429 counties in the South that had a 1996 P&S syphilis rate above 4.0 per 100,000 population, 188 (44%) had an increasing rate from 1995 to 1996 (Figure_T and Figure_U). Figure_T. South -- Primary and secondary syphilis case rates by county, 1996 Figure_U. South -- Increases and decreases in cases of primary and secondary syphilis in 1996 compared with 1995 cases, by county ---------- (1) Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, Mayaud P, Changalucha J, Nicoll A, ka-Gina G, Newell J, Mugeye K, Mabey D, Hayes R. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530-6.
This page last reviewed: Monday, February 01, 2016
This information is provided as technical reference material. Please contact us at cwus@cdc.gov to request a simple text version of this document.